Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Substitution/Harm Reduction in der Ukraine

The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine. 

The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine. 

Ivasiy R, Madden LM, Meteliuk A, Machavariani E, Ahmad B, Zelenev A, Desai MM, Bromberg DJ, Polonsky M, Galvez de Leon SJ, Farnum SO, Islam Z, Altice FL. 

Addiction. 2024 May 28. doi: 10.1111/add.16565. Epub ahead of print. PMID: 38807448.

Abstract

Conclusion

Ukraine’s prompt adoption of early take-home dosing for opioid agonist therapies, such as methadone, following the emergency COVID-19 guidance appears to have increased enrollment into methadone and improved treatment retention for people who inject drugs without adverse effects on patient survival.

https://onlinelibrary.wiley.com/doi/10.1111/add.16565